University of Mississippi Medical Center
Internal Medicine residency · Jackson, MS · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Mississippi Medical Center's research in internal medicine, which the program shares with other departments and affiliated hospitals.
About University of Mississippi Medical Centerinstitution-wide internal medicine research
Internal Medicine publications from University of Mississippi Medical Center and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
342
works per year
66th of 129 internal medicine residency programs
-9.9%
2-year growth
120th of 129 internal medicine residency programs
29.2%
in top 10% of field (works before 2025)
26th of 120 internal medicine residency programs
51.3%
cited above world average
27th of 120 internal medicine residency programs
Works per year · * 2026 so far
Cardiology and Cardiovascular Medicine · 635Infectious Diseases · 220Pulmonary and Respiratory Medicine · 161Endocrinology, Diabetes and Metabolism · 147Nephrology · 140
Internal Medicine research topics at University of Mississippi Medical Center
Papers in the window; each links to the list on OpenAlex.
- Heart Failure Treatment and Management 274
- HIV/AIDS Research and Interventions 87
- Chronic Kidney Disease and Diabetes 66
- Blood Pressure and Hypertension Studies 56
- Cardiac Fibrosis and Remodeling 47
- COVID-19 Clinical Research Studies 43
- Cardiovascular Function and Risk Factors 33
- SARS-CoV-2 and COVID-19 Research 29
Most cited at University of Mississippi Medical Center since 2024
All internal medicine papers there on OpenAlex
- Global epidemiology of heart failureMuhammad Shahzeb Khan et al. · Nature Reviews Cardiology · 2024 · PubMed · cited 603
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trialsJaved Butler et al. · The Lancet · 2024 · PubMed · cited 396
- Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trialsMikhail Kosiborod et al. · The Lancet · 2024 · PubMed · cited 323
- Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled TrialWissam A. Jaber et al. · Circulation · 2024 · PubMed · cited 226
- Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-AnalysisSiddharth M. Patel et al. · Circulation · 2024 · PubMed · cited 213
- Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trialsEllen M. Apperloo et al. · The Lancet Diabetes & Endocrinology · 2024 · PubMed · cited 177
- Efficacy and Safety of Dapagliflozin in Patients With Acute Heart FailureZachary L. Cox et al. · Journal of the American College of Cardiology · 2024 · PubMed · cited 159
- Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart FailureScott David Solomon et al. · Journal of the American College of Cardiology · 2024 · PubMed · cited 154
- Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysisMuhammad Usman et al. · The Lancet Diabetes & Endocrinology · 2024 · PubMed · cited 140